
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Octagam 10% is indicated for the treatment of chronic immune thrombocytopenic purpura in adults and dermatomyositis (DM) in adults
Octagam 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of:
Further, Octagam 10% is the first and only intravenous immunoglobulin to be indicated for the treatment of adult dermatomyositis.






